As of May 29
| -0.21 / -1.65%|
The 6 analysts offering 12-month price forecasts for Exone Co have a median target of 16.50, with a high estimate of 27.00 and a low estimate of 14.50. The median estimate represents a +31.47% increase from the last price of 12.55.
The current consensus among 9 polled investment analysts is to Hold stock in Exone Co. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.